|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Xi Y and Xu P: Global colorectal cancer
burden in 2020 and projections to 2040. Transl Oncol.
14(101174)2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM
and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Siegel RL, Miller KD, Goding Sauer A,
Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA and Jemal
A: Colorectal cancer statistics, 2020. CA Cancer J Clin.
70:145–164. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Punt CJA, Koopman M and Vermeulen L: From
tumour heterogeneity to advances in precision treatment of
colorectal cancer. Nat Rev Clin Oncol. 14:235–246. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bommer UA and Thiele BJ: The
translationally controlled tumour protein (TCTP). Int J Biochem
Cell Biol. 36:379–385. 2004.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Thiele H, Berger M, Skalweit A and Thiele
BJ: Expression of the gene and processed pseudogenes encoding the
human and rabbit translationally controlled tumour protein (TCTP).
Eur J Biochem. 267:5473–5481. 2000.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bommer UA, Borovjagin AV, Greagg MA,
Jeffrey IW, Russell P, Laing KG, Lee M and Clemens MJ: The mRNA of
the translationally controlled tumor protein P23/TCTP is a highly
structured RNA, which activates the dsRNA-dependent protein kinase
PKR. RNA. 8:478–496. 2002.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Nielsen HV, Johnsen AH, Sanchez JC,
Hochstrasser DF and Schiøtz PO: Identification of a basophil
leukocyte interleukin-3-regulated protein that is identical to
IgE-dependent histamine-releasing factor. Allergy. 53:642–652.
1998.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Thaw P, Baxter NJ, Hounslow AM, Price C,
Waltho JP and Craven CJ: Structure of TCTP reveals unexpected
relationship with guanine nucleotide-free chaperones. Nat Struct
Biol. 8:701–704. 2001.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Gachet Y, Tournier S, Lee M,
Lazaris-Karatzas A, Poulton T and Bommer UA: The growth-related,
translationally controlled protein P23 has properties of a tubulin
binding protein and associates transiently with microtubules during
the cell cycle. J Cell Sci. 112:1257–1271. 1999.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Li F, Zhang D and Fujise K:
Characterization of fortilin, a novel antiapoptotic protein. J Biol
Chem. 276:47542–47549. 2001.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tuynder M, Susini L, Prieur S, Besse S,
Fiucci G, Amson R and Telerman A: Biological models and genes of
tumor reversion: Cellular reprogramming through tpt1/TCTP and
SIAH-1. Proc Natl Acad Sci USA. 99:14976–14981. 2002.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Rho SB, Lee JH, Park MS, Byun HJ, Kang S,
Seo SS, Kim JY and Park SY: Anti-apoptotic protein TCTP controls
the stability of the tumor suppressor p53. FEBS Lett. 585:29–35.
2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Amson R, Pece S, Lespagnol A, Vyas R,
Mazzarol G, Tosoni D, Colaluca I, Viale G, Rodrigues-Ferreira S,
Wynendaele J, et al: Reciprocal repression between P53 and TCTP.
Nat Med. 18:91–99. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
16
|
Lucibello M, Gambacurta A, Zonfrillo M,
Pierimarchi P, Serafino A, Rasi G, Rubartelli A and Garaci E: TCTP
is a critical survival factor that protects cancer cells from
oxidative stress-induced cell-death. Exp Cell Res. 317:2479–2489.
2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sinha P, Kohl S, Fischer J, Hütter G, Kern
M, Köttgen E, Dietel M, Lage H, Schnölzer M and Schadendorf D:
Identification of novel proteins associated with the development of
chemoresistance in malignant melanoma using two-dimensional
electrophoresis. Electrophoresis. 21:3048–3057. 2000.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Graidist P, Phongdara A and Fujise K:
Antiapoptotic protein partners fortilin and MCL1 independently
protect cells from 5-fluorouracil-induced cytotoxicity. J Biol
Chem. 279:40868–40875. 2004.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chan THM, Chen L and Guan XY: Role of
translationally controlled tumor protein in cancer progression.
Biochem Res Int. 2012(369384)2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Telerman A and Amson R: The molecular
programme of tumour reversion: The steps beyond malignant
transformation. Nat Rev Cancer. 9:206–216. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Lucibello M, Adanti S, Antelmi E, Dezi D,
Ciafrè S, Carcangiu ML, Zonfrillo M, Nicotera G, Sica L, De Braud F
and Pierimarchi P: Phospho-TCTP as a therapeutic target of
Dihydroartemisinin for aggressive breast cancer cells. Oncotarget.
6:5275–5291. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ma Q, Geng Y, Xu W, Wu Y, He F, Shu W,
Huang M, Du H and Li M: The role of translationally controlled
tumor protein in tumor growth and metastasis of colon
adenocarcinoma cells. J Proteome Res. 9:40–49. 2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Miao X, Chen YB, Xu SL, Zhao T, Liu JY, Li
YR, Wang J, Zhang J and Guo GZ: TCTP overexpression is associated
with the development and progression of glioma. Tumour Biol.
34:3357–3361. 2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Amson R, Pece S, Marine JC, Di Fiore PP
and Telerman A: TPT1/TCTP-regulated pathways in phenotypic
reprogramming. Trends Cell Biol. 23:37–46. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhang D, Li F, Weidner D, Mnjoyan ZH and
Fujise K: Physical and functional interaction between myeloid cell
leukemia 1 protein (MCL1) and Fortilin. The potential role of MCL1
as a fortilin chaperone. J Biol Chem. 277:37430–37438.
2002.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Xiao B, Chen D, Luo S, Hao W, Jing F, Liu
T, Wang S, Geng Y, Li L, Xu W, et al: Extracellular translationally
controlled tumor protein promotes colorectal cancer invasion and
metastasis through Cdc42/JNK/MMP9 signaling. Oncotarget.
7:50057–50073. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Fischer N, Saeed MEM, Lippe E, Roth W and
Efferth T: High TCTP expression as prognostic factor in different
cancer types. World Acad Sci J. 3(3)2021.
|
|
28
|
McCarty K Jr, Miller LS, Cox EB, Konrath J
and McCarty K Sr: Estrogen receptor analyses. Correlation of
biochemical and immunohistochemical methods using monoclonal
antireceptor antibodies. Arch Pathol Lab Med. 109:716–721.
1985.PubMed/NCBI
|
|
29
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chan THM, Chen L, Liu M, Hu L, Zheng BJ,
Poon VK, Huang P, Yuan YF, Huang JD, Yang J, et al: Translationally
controlled tumor protein induces mitotic defects and chromosome
missegregation in hepatocellular carcinoma development. Hepatology.
55:491–505. 2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Chen C, Deng Y, Hua M, Xi Q, Liu R, Yang
S, Liu J, Zhong J, Tang M, Lu S, et al: Expression and clinical
role of TCTP in epithelial ovarian cancer. J Mol Histol.
46:145–156. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Tuynder M, Fiucci G, Prieur S, Lespagnol
A, Géant A, Beaucourt S, Duflaut D, Besse S, Susini L, Cavarelli J,
et al: Translationally controlled tumor protein is a target of
tumor reversion. Proc Natl Acad Sci USA. 101:15364–15369.
2004.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Gnanasekar M, Thirugnanam S, Zheng G, Chen
A and Ramaswamy K: Gene silencing of translationally controlled
tumor protein (TCTP) by siRNA inhibits cell growth and induces
apoptosis of human prostate cancer cells. Int J Oncol.
34:1241–1246. 2009.PubMed/NCBI
|
|
34
|
Bommer UA, Vine KL, Puri P, Engel M,
Belfiore L, Fildes K, Batterham M, Lochhead A and Aghmesheh M:
Translationally controlled tumour protein TCTP is induced early in
human colorectal tumours and contributes to the resistance of
HCT116 colon cancer cells to 5-FU and oxaliplatin. Cell Commun
Signal. 15(9)2017.PubMed/NCBI View Article : Google Scholar
|
